Research graph
References from Efficacy of celecoxib and methotrexate–vinblastine regimen in desmoid-type fibromatosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Biology and treatment of aggressive fibromatosis or desmoid tumor.
10.1016/j.mayocp.2017.02.012 · 2017 · External reference
Surgical management of soft tissue tumors of the abdominal wall: a retrospective study in a high-volume sarcoma center.
10.1002/jso.26566 · 2021 · External reference
Surgical resection margins in desmoid-type fibromatosis: a critical reassessment.
10.1097/pas.0000000000000276 · 2014 · External reference
The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients.
10.1016/j.ejca.2019.11.013 · 2020 · External reference
Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing.
10.1080/15384047.2017.1373215 · 2017 · External reference
Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis.
10.1007/s10637-017-0542-0 · 2018 · External reference
Systemic chemotherapies retain antitumor activity in desmoid tumors independent of specific mutations in CTNNB1 or APC: a multi-institutional retrospective study.
10.1158/1078-0432.ccr-21-4504 · 2022 · External reference
Preclinical efficacy of the Wnt/beta-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.
10.1371/journal.pone.0276047 · 2022 · External reference
Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways.
10.1093/carcin/bgy038 · 2018 · External reference
Extra-abdominal desmoid fibromatosis: an evaluation of clinical factors affecting local recurrence rates.
10.5152/j.aott.2021.21033 · 2021 · External reference
Complete remission of pancreatic head desmoid tumor treated by COX-2 inhibitor-a case report.
10.1186/s12957-016-0944-z · 2016 · External reference
Desmoids: a revelation in biology and treatment.
10.1245/s10434-008-0285-4 · 2009 · External reference
Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: a phase II clinical trial.
10.1111/cas.14626 · 2020 · External reference
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
10.1016/s1470-2045(19)30276-1 · 2019 · External reference
Radiotherapy in the treatment of primary or recurrent unresectable desmoid tumors of the neck.
10.1080/07357907.2019.1656731 · 2019 · External reference
Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.
10.1093/jjco/hyab146 · 2021 · External reference
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
10.1016/j.ejca.2008.10.026 · 2009 · External reference
Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.
10.1200/jco.1999.17.1.158 · 1999 · External reference
The enigma of desmoid tumors.
10.1097/00000658-199906000-00014 · 1999 · External reference
Immunological aspects of neoplasia.
1975 · External reference
Long-term efficacy of methotrexate plus vinblastine/vinorelbine in a large series of patients affected by desmoid-type fibromatosis.
10.1097/ppo.0000000000000254 · 2017 · External reference
Nirogacestat, a γ-secretase inhibitor for desmoid tumors.
10.1056/nejmoa2210140 · 2023 · External reference
Current management of desmoid tumors: a review.
10.1001/jamaoncol.2024.1805 · 2024 · External reference
Desmoid tumors: old and new drugs for a rare and challenging disease.
10.1002/cncr.35603 · 2025 · External reference
Current management of desmoid tumors: a review.
10.1001/jamaoncol.2024.1805 · ExternalCitation · doi-reference
Desmoid tumors: old and new drugs for a rare and challenging disease.
10.1002/cncr.35603 · ExternalCitation · doi-reference
Surgical management of soft tissue tumors of the abdominal wall: a retrospective study in a high-volume sarcoma center.
10.1002/jso.26566 · ExternalCitation · doi-reference
Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis.
10.1007/s10637-017-0542-0 · ExternalCitation · doi-reference
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
10.1016/j.ejca.2008.10.026 · ExternalCitation · doi-reference
The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients.
10.1016/j.ejca.2019.11.013 · ExternalCitation · doi-reference
Biology and treatment of aggressive fibromatosis or desmoid tumor.
10.1016/j.mayocp.2017.02.012 · ExternalCitation · doi-reference
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
10.1016/s1470-2045(19)30276-1 · ExternalCitation · doi-reference
Nirogacestat, a γ-secretase inhibitor for desmoid tumors.
10.1056/nejmoa2210140 · ExternalCitation · doi-reference
Radiotherapy in the treatment of primary or recurrent unresectable desmoid tumors of the neck.
10.1080/07357907.2019.1656731 · ExternalCitation · doi-reference
Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing.
10.1080/15384047.2017.1373215 · ExternalCitation · doi-reference
Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways.
10.1093/carcin/bgy038 · ExternalCitation · doi-reference
Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.
10.1093/jjco/hyab146 · ExternalCitation · doi-reference
The enigma of desmoid tumors.
10.1097/00000658-199906000-00014 · ExternalCitation · doi-reference
Surgical resection margins in desmoid-type fibromatosis: a critical reassessment.
10.1097/pas.0000000000000276 · ExternalCitation · doi-reference
Long-term efficacy of methotrexate plus vinblastine/vinorelbine in a large series of patients affected by desmoid-type fibromatosis.
10.1097/ppo.0000000000000254 · ExternalCitation · doi-reference
Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: a phase II clinical trial.
10.1111/cas.14626 · ExternalCitation · doi-reference
Systemic chemotherapies retain antitumor activity in desmoid tumors independent of specific mutations in CTNNB1 or APC: a multi-institutional retrospective study.
10.1158/1078-0432.ccr-21-4504 · ExternalCitation · doi-reference
Complete remission of pancreatic head desmoid tumor treated by COX-2 inhibitor-a case report.
10.1186/s12957-016-0944-z · ExternalCitation · doi-reference
Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.
10.1200/jco.1999.17.1.158 · ExternalCitation · doi-reference
Desmoids: a revelation in biology and treatment.
10.1245/s10434-008-0285-4 · ExternalCitation · doi-reference
Preclinical efficacy of the Wnt/beta-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.
10.1371/journal.pone.0276047 · ExternalCitation · doi-reference
Extra-abdominal desmoid fibromatosis: an evaluation of clinical factors affecting local recurrence rates.
10.5152/j.aott.2021.21033 · ExternalCitation · doi-reference
